Tradestie Institutional Equity Comparison Engine
IVF vs ILLR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IVF Overall Edge
IVF Captures Institutional Edge (3โ0 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to INVO Fertility, Inc. Common Stock (IVF) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, IVF trades at N/M Forward P/E with -78.7% operating margin (+16.7% YoY revenue) versus ILLR at N/M Forward P/E and -432.7% operating margin (-5.2% YoY). In options structure, IVF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ILLR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
IVF
IVF N/M vs ILLR N/M Fwd P/E
Growth & Margin Winner
IVF
Op Margin -78.7% vs -432.7% ยท YoY +16.7% vs -5.2%
Momentum & Technical Winner
IVF
1Y +376.9% vs -76.1% ยท 52W Pos 49% vs 1%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
IVF
NASDAQ
INVO Fertility, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$2.38
-8.46% 1D
Market Cap
$3.2M
1M Return
+326.83%
1Y Return
+376.95%
Forward P/E
N/M
Unified AI Score
29.8 / 100
SELL
Tech 50.0
Fund 26.0
Flow 50.0
Mom 34.0
ILLR
NASDAQ
Triller Group Inc. Common Stock
Investment Advice
$0.18
-23.04% 1D
Market Cap
$4.7M
1M Return
-80.49%
1Y Return
-76.08%
Forward P/E
N/M
Unified AI Score
48.6 / 100
HOLD
Tech 45.0
Fund 49.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IVF +376.95%
ILLR -76.08%
Spread: +125.04 pp (IVF Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | IVF Revenue | ILLR Revenue | IVF Op. Margin | ILLR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -532.8% | N/A | IVF |
| FY2019 | $0M | N/A | -120.8% | N/A | IVF |
| FY2020 | $0M | N/A | -531.7% | N/A | IVF |
| FY2021 | $0M | $10M | -125.4% | -73.7% | ILLR |
| FY2022 | $0M | $30M | -1292.5% | -91.2% | ILLR |
| FY2023 | $0M | $50M | -224.0% | -79.5% | ILLR |
| FY2024 | $10M | $30M | -101.0% | -411.9% | IVF |
| FY2025 | $10M | $20M | -105.8% | -640.1% | IVF |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IVF | ILLR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.2M | $4.7M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 0.0x | N/M | Lower Multiple | IVF |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +16.7% | -5.2% | Higher Growth | IVF |
| Operating Margin (TTM) Profitability | -78.7% | -432.7% | Higher Margin | IVF |
| Net Profit Margin Profitability | -92.3% | 0.0% | Higher Margin | ILLR |
| Return on Equity (ROE) Capital Efficiency | -72.7% | 0.0% | Higher ROE | ILLR |
| 52-Week Range Position Momentum | 49% ($0โ$5) | 1% ($0โ$5) | Stronger Trend | IVF |
| Beta / 30D Volatility Risk Regime | -7.15ฮฒ ยท 888% Vol | -10.16ฮฒ ยท 177% Vol | Lower Realized Risk | ILLR |
| Unified Institutional Score Composite Signal | 29.8 / 100 (SELL) | 48.6 / 100 (HOLD) | Higher Composite | ILLR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IVF vs ILLR Buy Guide
IVF
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ILLR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IVF nor ILLR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.